199 related articles for article (PubMed ID: 17329499)
1. Selective activation of liver X receptors by acanthoic acid-related diterpenes.
Traves PG; Hortelano S; Zeini M; Chao TH; Lam T; Neuteboom ST; Theodorakis EA; Palladino MA; Castrillo A; Bosca L
Mol Pharmacol; 2007 Jun; 71(6):1545-53. PubMed ID: 17329499
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
3. Regulation of sphingomyelin phosphodiesterase acid-like 3A gene (SMPDL3A) by liver X receptors.
Noto PB; Bukhtiyarov Y; Shi M; McKeever BM; McGeehan GM; Lala DS
Mol Pharmacol; 2012 Oct; 82(4):719-27. PubMed ID: 22810003
[TBL] [Abstract][Full Text] [Related]
4. Physiological differences between human and rat primary hepatocytes in response to liver X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propyloxy]phenylacetic acid hydrochloride (GW3965).
Kotokorpi P; Ellis E; Parini P; Nilsson LM; Strom S; Steffensen KR; Gustafsson JA; Mode A
Mol Pharmacol; 2007 Oct; 72(4):947-55. PubMed ID: 17628011
[TBL] [Abstract][Full Text] [Related]
5. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
[TBL] [Abstract][Full Text] [Related]
6. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
8. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.
Ma Y; Xu L; Rodriguez-Agudo D; Li X; Heuman DM; Hylemon PB; Pandak WM; Ren S
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1369-79. PubMed ID: 18854425
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages.
Fontaine C; Rigamonti E; Nohara A; Gervois P; Teissier E; Fruchart JC; Staels B; Chinetti-Gbaguidi G
Circ Res; 2007 Jul; 101(1):40-9. PubMed ID: 17540978
[TBL] [Abstract][Full Text] [Related]
10. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
[TBL] [Abstract][Full Text] [Related]
11. Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3).
Wada T; Kang HS; Angers M; Gong H; Bhatia S; Khadem S; Ren S; Ellis E; Strom SC; Jetten AM; Xie W
Mol Pharmacol; 2008 Mar; 73(3):891-9. PubMed ID: 18055760
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor agonists inhibit tissue factor expression in macrophages.
Terasaka N; Hiroshima A; Ariga A; Honzumi S; Koieyama T; Inaba T; Fujiwara T
FEBS J; 2005 Mar; 272(6):1546-56. PubMed ID: 15752369
[TBL] [Abstract][Full Text] [Related]
13. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.
Han X; Cui ZY; Song J; Piao HQ; Lian LH; Hou LS; Wang G; Zheng S; Dong XX; Nan JX; Wu YL
Chem Biol Interact; 2019 Sep; 311():108794. PubMed ID: 31421115
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptors and cholesterol homoeostasis: spotlight on the adrenal gland.
Cummins CL; Mangelsdorf DJ
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1110-3. PubMed ID: 17073762
[TBL] [Abstract][Full Text] [Related]
15. CYP3A induction by liver x receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor.
Shenoy SD; Spencer TA; Mercer-Haines NA; Alipour M; Gargano MD; Runge-Morris M; Kocarek TA
Drug Metab Dispos; 2004 Jan; 32(1):66-71. PubMed ID: 14709622
[TBL] [Abstract][Full Text] [Related]
16. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice.
Peng D; Hiipakka RA; Dai Q; Guo J; Reardon CA; Getz GS; Liao S
J Pharmacol Exp Ther; 2008 Nov; 327(2):332-42. PubMed ID: 18723776
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
[TBL] [Abstract][Full Text] [Related]
18. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.
Mitro N; Vargas L; Romeo R; Koder A; Saez E
FEBS Lett; 2007 May; 581(9):1721-6. PubMed ID: 17418145
[TBL] [Abstract][Full Text] [Related]
19. The human ADFP gene is a direct liver-X-receptor (LXR) target gene and differentially regulated by synthetic LXR ligands.
Kotokorpi P; Venteclef N; Ellis E; Gustafsson JA; Mode A
Mol Pharmacol; 2010 Jan; 77(1):79-86. PubMed ID: 19843633
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol efflux is LXRα isoform-dependent in human macrophages.
Ma AZ; Song ZY; Zhang Q
BMC Cardiovasc Disord; 2014 Jul; 14():80. PubMed ID: 24996838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
